Sign in
Taking people in United StatesNo phase

Comparing two types of flow diverter devices for brain aneurysms

Looks back at adults with intracranial aneurysm treated with two kinds of flow diverter devices.

Key facts

Who runs it
Montefiore Medical Center
Where
Buffalo, Burlington, Coral Gables, Danville, Jacksonville, Kingwood, Minneapolis, New Brunswick, Sarasota, The Bronx, and Traverse City, United StatesSee the 11 sitesAlso in 1 other country, 2 sites
Trial code
Registry title
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
Status
Recruiting
People taking part
5,000 people, planned
Started
1 Oct 2023
Expected to end
Jul 2027
Type of study
Observational, 2 groups
Record updated
21 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults whose brain aneurysm (a bulge in a brain blood vessel) was already treated with a flow diverter stent or a device placed inside the aneurysm. It studies past medical records.

Age
18 years or older
Sex
All sexes
Disease stage
Intracranial aneurysm (a bulge in a blood vessel in the brain)
Earlier treatment
Must have had treatment through the blood vessels with one of the listed devices. Flow diverter stents: Pipeline Flex, Pipeline Flex with Shield Technology, Surpass Streamline, Surpass Evolve, Silk, FRED, FRED X, p64, eCLIPs. Devices inside the aneurysm: WEB, Luna/Artisse, Medina, Contour, Neqstent, pCONus and pCANvas, Nexus, CITADEL.

Main reasons for not taking part

  • Incomplete treatment or follow-up records
  • Treatment without a flow diverter or flow disruptor, such as coiling only
  • Treatment with experimental devices not on the list

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Consecutive adult patients (18 years of age or older)
  • Underwent endovascular treatment with one of the following devices:; Endoluminal Flow Diverter Stents: i. Pipeline Flex (Covidien, California, USA) ii. Pipeline Flex with Shield Technology (Covidien) iii. Surpass Streamline (Stryker Neurovascular, California, USA) iv. Surpass Evolve (Stryker) v. Silk flow diverter (Balt Extrusion, Montmorency, France) vi. Flow-Redirection Intraluminal Device (FRED; MicroVention) vii. Flow-Redirection Intraluminal Device X (FRED X; MicroVention) viii. p64 Flow Modulation Device (phenox GmbH) ix. Endovascular clip system (eCLIPs) (eCLIPsTM, eVasc Neurovascular, Vancouver, BC, Canada); Intrasaccular Flow Disruptors: i. Woven EndoBridge (WEB; MicroVention) ii. Luna/Artisse System (Medtronic) iii. Medina Embolic Device (Medtronic) iv. Contour Neurovascular System (Cerus Endovascular) v. Neqstent Coil Assisted Flow Diverter (Cerus Endovascular) vi. pCONus and pCANvas (phenox GmbH) vii. Nexus Aneurysm Embolization System (EndoStream Medical) viii. CITADEL™ Embolization Device (Balt, USA)
  • Complete medical records and follow-up data available

Who cannot take part

  • Aneurysms treated with investigational devices not listed within Inclusion Criteria
  • Incomplete procedural or follow-up records
  • Non-flow-diverter or non-flow-disruptor treatments (e.g., coiling-only cases)

Where in United States

Also in 1 other country, 2 sites

  • University at BuffaloBuffalo, United StatesContact: Muhammed Amir Essibayi, MDNo longer taking part
  • Lahey Hospital and Medical CenterBurlington, United StatesContact: Timo Krings, MD, PhD, MScTaking people
  • University of MiamiCoral Gables, United StatesContact: Robert M Starke, MD, MSTaking people
  • Geisinger HealthDanville, United StatesContact: Muhammed Amir Essibayi, MDNo longer taking part
  • Mayo Clinic FloridaJacksonville, United StatesContact: Muhammed Amir Essibayi, MDNo longer taking part
  • HCA Houston Healthcare KingwoodKingwood, United StatesContact: Muhammed Amir Essibayi, MDNo longer taking part
  • Allina HealthMinneapolis, United StatesContact: Collin M Torok, MDTaking people
  • Robert Wood Johnson UniversityNew Brunswick, United StatesContact: Gaurav Gupta, MDTaking people
  • Sarasota Memorial Research InstituteSarasota, United StatesContact: Muhammed Amir Essibayi, MDNo longer taking part
  • Montefiore Medical Center Department of NeurosurgeryThe Bronx, United StatesContact: Muhammed Amir Essibayi, MDTaking people
  • Munson Medical CenterTraverse City, United StatesContact: Amy Peterson, PhDTaking people

About the trial

What the trial wants to find out

This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.

The 2 groups in the trial

  • Endoluminal Flow Diverter Stent

    Adults with intracranial aneurysms treated with an endoluminal flow diverter stent as part of routine care.

  • Intrasaccular Flow Disruptor

    Adults with intracranial aneurysms treated with an intrasaccular flow disruptor as part of routine care.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Outcomes of Intra-arterial and Endosaccular Flow Diverters for Treatment of Intracranial Aneurysms - International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
Plain-language title
Comparing two types of flow diverter devices for brain aneurysmsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 September 2026